Shanghai Model Organisms Center CFO Steps Down

Shanghai Model Organisms Center (SHA:688265) said CFO Zhou Rongxin resigned due to personal reasons, as per a Friday filing on the Shanghai bourse. Wang Mingjun, a director and general manager, is nam

MT NewswiresJun 30 20:49 ET

Nanmo Biotech (688265.SH): The repurchase period has expired and a total of 1.0119% of the company's shares have been repurchased

Gelonghui, May 22丨Nanmo Biotech (688265.SH) announced that as of May 22, 2024, the company's share repurchase period has expired, and the implementation of the share repurchase plan has been completed. The company bought back 788,912 shares of the company through centralized bidding transactions through the Shanghai Stock Exchange trading system, accounting for 1.0119% of the company's total share capital of 77,963,513 shares. The highest price of the repurchase transaction was 29.98 yuan/share, the lowest price was 23.90 yuan/share, and the total capital paid was RMB 21.453.59 million (excluding taxes, transaction commissions, etc.)

Gelonghui FinanceMay 22 06:12 ET

Nanmo Biotech (688265.SH): Repurchase 1.0119% of shares through centralized bidding

Gelonghui, May 7, 丨 Nanmo Biotech (688265.SH) announced that as of April 30, 2024, the company had repurchased 788,912 shares through the Shanghai Stock Exchange trading system, accounting for 1.0119% of the company's total share capital of 77,963,513 shares. The highest price of the repurchase transaction was 29.98 yuan/share, the lowest price was 23.90 yuan/share, and the total amount of capital paid was RMB 21.453.59 million (excluding transaction fees such as taxes and transaction fees).

Gelonghui FinanceMay 7 06:04 ET

Nanmo Biotech (688265.SH) announced first-quarter results with a net loss of 12.8971 million yuan

Nanmo Biotech (688265.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved an operating income of 8...

Zhitong FinanceApr 29 13:07 ET

Nanmo Biotech (688265.SH): A total cost of 14.964 million yuan to buy back 0.69% of the shares

Gelonghui, April 1, 丨 Nanmo Biotech (688265.SH) announced that as of March 31, 2024, the company had repurchased 538,911 shares through the Shanghai Stock Exchange trading system, accounting for 0.6912% of the company's total share capital of 77,963,513 shares. The highest price of the repurchase transaction was 29.98 yuan/share, the lowest price was 26.03 yuan/share, and the total amount of capital paid was RMB 14.96.44.42 million (excluding transaction fees such as taxes and transaction fees).

Gelonghui FinanceApr 1 04:11 ET

Nanmo Biotech (688265.SH): 1.1283% of shares have been repurchased

Gelonghui, March 26, 丨 Nanmo Biotech (688265.SH) announced that as of March 25, 2024, the company had repurchased a total of 889.6.67 million shares through centralized bidding transactions, accounting for 1.1283% of the company's total share capital, an increase of 0.5119 percent compared with the previous disclosure. The highest purchase price was 40.99 yuan/share, the lowest price was 26.03 yuan/share, and the total amount paid was 28.412.58 million yuan (excluding transaction fees such as taxes and transaction fees).

Gelonghui FinanceMar 26 06:03 ET